WOCKHARDT LIMITED Valuation

WOCKPHARMA · Healthcare · Current price ₹1,849.9

Full stock page
DocStoX fair value
₹332
medium confidence
Current price
₹1,850
Upside
-82.1%
P/E ratio
141.1x
P/B ratio
10.3x
Verdict
Avoid
Model it yourself — Earnings Yield Calculator
Opens pre-filled with WOCKHARDT LIMITED's latest numbers.

Is WOCKHARDT LIMITED undervalued?

DocStoX estimates the fair value of WOCKHARDT LIMITED at ₹332 per share, versus the current market price of ₹1,850. That puts the stock about -82.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is medium.

How this fair value is calculated

This estimate blends 3 independent methods: Residual income (₹279), Relative P/E (₹455), Graham floor (₹299). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹279 (bear) to ₹332 (base) to ₹455 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Valuation multiples

WOCKHARDT LIMITED trades at a P/E of 141.1x and a P/B of 10.3x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on WOCKHARDT LIMITED

Fair ValueIntrinsic ValueDCFFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.